You just read:

Lilly Receives U.S. FDA Approval for Taltz® (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)

News provided by

Eli Lilly & Company

Aug 26, 2019, 06:45 ET